Evidence now implicates not only maternal immune activation (MIA) from infection or inflammation during pregnancy, but also maternal autoimmune disease, environmental toxicant exposure, and cerebral folate deficiency mediated by folate receptor alpha autoantibodies in the etiology and symptomatology of ASD [2,3,4]. This evidence concerns the gene FOLR1 and autoimmune disease.